GT Biopharma Inc
Change company Symbol lookup
Select an option...
GTBP GT Biopharma Inc
UNH UnitedHealth Group Inc
BAC Bank of America Corp
WSO Watsco Inc
LITB LightInTheBox Holding Co Ltd
CVCY Central Valley Community Bancorp
AFAQU AF Acquisition Corp
HCIIW Hudson Executive Investment Equity II Warrant Exp 31 Jan 2027 *W EXP 01/31/2027
MEDS TRxADE Health Inc
HCICW Hennessy Capital Investment V Equity Warrant Exp 15 Jan 2025 *W EXP 01/15/2025
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

GT Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. The Company's TriKE platform generate therapeutics designed to harness and enhance the cancer killing abilities of a patient's own natural killer (NK) cells. GTB-3550 is the Company's TriKE product candidate, which is a single-chain, tri-specific recombinant fusion protein construct consisting of the variable regions of the heavy and light chains of anti-CD16 and anti-CD33 antibodies and a modified form of IL-15. The Company is focused on studying this anti-CD16-IL-15-anti-CD33 TriKE in CD33 positive leukemias, a marker expressed on tumor cells in acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS).

Closing Price
$2.47
Day's Change
0.41 (19.90%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.48
Day's Low
2.10
Volume
(Average)
Volume:
171,097

10-day average volume:
170,736
171,097

Netflix sheds nearly $50 billion in market cap after 'borderline catastrophic' forecast

4:57 pm ET January 21, 2022 (MarketWatch)
Print

By Jon Swartz and Jeremy C. Owens

Executives expect less than half the net new subscribers that analysts projected for the first quarter of 2022, shares fall 21.8%

Netflix Inc. brought in more than 8 million new subscribers in the holiday quarter, but executives predicted that growth would suffer much more than expected at the beginning of 2022, sending shares screaming lower Friday.

Netflix (NFLX) on Thursday afternoon reported 8.3 million net new paid subscribers in the fourth quarter, trailing its own forecast for 8.5 million but roughly hitting the average analyst forecast of 8.3 million, according to FactSet, and giving the streaming-video service 221.8 million subscribers overall as of the end of 2021.

The number allayed the stark warnings of some analysts, including JPMorgan's Doug Anmuth, who had feared a significant shortfall of new subscribers, but executives do see a precipitous slowdown ahead -- they predicted just 2.5 million net new subscribers in the first quarter, less than half the 5.8 million that analysts were projecting on average, according to FactSet.

Netflix shares plummeted 21.8% Friday, lopping off $49.1 billion in market capitalization from the streaming giant, which had ended Thursday's trading session worth about $225 billion. That decline is more than the total market cap of Zoom Video Communications Inc. (ZM), which was worth less than $47 billion as of Friday, and streaming-music company Spotify Technology SA (SPOT), which has a market cap of less than $40 billion.

In a video call following the results, Netflix Chief Financial Officer Spencer Neumann said it was tough to pinpoint why net new subscribers are plunging, but it could be attributable to "COVID overhang" after two years and a "marginal impact from competition."

Opinion: Netflix admits that it is time to grow up, but Wall Street isn't happy about it

Netflix executives said that a lack of new original programming, especially early in the quarter, was a factor in their forecast. Netflix unloaded a wealth of new content in the holiday quarter, including new seasons of popular TV hits like "The Witcher" and "Emily in Paris" as well as some of the biggest movies the service has ever launched, like "Don't Look Up" and "Red Notice," and isn't expecting big new releases until later in 2022.

"Our guidance reflects a more back-end weighted content slate in Q1'22 (for example, 'Bridgerton' S2 and our new original film 'The Adam Project' will both be launching in March)," they wrote in a letter to shareholders announcing the results. "In addition, while retention and engagement remain healthy, acquisition growth has not yet re-accelerated to pre-COVID levels. We think this may be due to several factors including the ongoing COVID overhang and macro-economic hardship in several parts of the world."

Netflix's subscriber growth has waned as the COVID-19 pandemic has marched on, and the streaming service added 18.2 million new subscribers total in 2021, fewer than it added in just the first six months of 2020, when the virus first spread across the globe and caused a wave of shelter-in-place restrictions.

See also: Some on Wall Street want Netflix to stop reporting subscriber growth

As subscriber growth has slowed, Netflix has looked to increase prices in mature markets to continue to grow revenue. After hiking prices in October 2020 for the U.S. and Canada, Netflix confirmed last week it is doing so again for that region, pushing the price of its basic plan higher than the cost of AT&T Inc.'s (T) HBO Max streaming service.

Netflix's recent subscription price increase signaled the top of the company's domestic growth potential, with 74 million households in the U.S. and Canada, Berna Barshay, an analyst at Empire Financial Research, told MarketWatch.

"The subscription guide was borderline catastrophic, and they ran into the law of large numbers" with a stock price at a huge valuation, she added.

Netflix said its sales grew to $7.71 billion in the holiday quarter, up from $6.6 billion in the same period a year ago. Profit was expected to decline as a wave of premieres required Netflix to recognize the costs of expensive content such as the newest season of "The Witcher," but the company reported earnings of $607 billion, or $1.33 a share, up from $1.19 a share a year ago. Analysts polled by FactSet expected earnings of 83 cents a share on sales of $7.71 billion.

Read: Here's what's coming to Netflix in February 2022 -- along with a price hike

Netflix continues to command viewer loyalty worldwide -- 70% of its desktop visitors watched it exclusively -- despite a glut of competition from HBO, Apple Inc. (AAPL), Walt Disney Co. (DIS), Amazon.com Inc. (AMZN), Comcast Corp. (CMCSA), ViacomCBS Inc. (VIAC) and others, based on figures from data intelligence platform Similarweb in December 2021. Similarweb noted that fewer consumers are canceling Netflix, based on a decline in cancellation rate.

Still, Netflix's vice-like grip on the market has slipped the past two years as competition has escalated, according to one research firm. From the second quarter of 2020 to the fourth quarter of 2021, Apple TV+, Disney+ and HBO Max combined grew from 10.6% to 20.6% of global interest among consumers, while Netflix dropped from 55% to 45.4%, Julia Alexander, a senior analyst at Parrot Analytics, told MarketWatch.

Netflix executives admitted in their letter to shareholders that competition was affecting growth, the first time they have made that admission in a regular quarterly update on the competition.

"While this added competition may be affecting our marginal growth some, we continue to grow in every country and region in which these new streaming alternatives have launched," the executives wrote, later adding that "with under 10% of total TV screen time in the U.S., our biggest market, Netflix has tremendous room for growth if we can continue to improve our service."

Netflix stock is down more than 30% over the past 12 months with Friday's sell-off; the broader S&P 500 index has improved 16.3% in the past year.

-Jon Swartz

	

(END) Dow Jones Newswires

January 21, 2022 16:57 ET (21:57 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.